BioSpace News Archive

Sutro Biopharma, Inc. announced that Chief Executive Officer, Bill Newell, will participate in two upcoming investor conferences.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that treatment with AXS-05 (dextromethorphan-bupropion) rapidly and significantly reduced anhedonic symptoms in the GEMINI Phase 3 trial in major depressive disorder (MDD).

Finch Therapeutics Group, Inc. announced that Mark Smith, PhD, Chief Executive Officer, will participate in fireside chats at the following investor conferences.

Renalytix plc announced its participation at the American Diabetes Association 82nd Scientific Sessions® meeting in New Orleans from June 3-7, 2022.

Pathalys Pharma, Inc., a private, late-stage biopharma company committed to the development and commercialization of a range of best-in-class therapies for patients with end stage kidney disease (ESKD), today announced that Neal Fowler, Chief Executive Officer, will present a company overview at the Jefferies Health Conference.

Genprex, Inc. today announced the Company’s participation in the following upcoming investor and industry conferences to be held in June 2022.

Vernal Biosciences, a technology-leading mRNA manufacturer and formulator of LNP-mRNA, announced today the completion of a $21 million financing to fully integrate its mRNA manufacturing solutions.

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Biotrue ® Hydration Plus Multi-Purpose Solution.

ESSA Pharma Inc. today announced that the Company will be presenting at the 2022 Jefferies Healthcare Conference.

Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 4:30 p.m. ET.